Saturday 17 October 2026
Export IRIX’s income statement to Excel — free account
IRIDEX Corporation
IRIX Healthcare Medical Devices
IRIDEX Corporation’s revenue for fiscal 2025 (year ended December 2025) was $52.7 million, up 8.23% from fiscal 2024. In the quarter to June 2026, revenue fell 7.41%, EPS fell 16.7%, free cash flow grew 130.2% and total debt rose 3.27%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
0.81
0.01
−1.22%
Follow IRIX
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
Piotroski F-Score |
+8 more TTM periods Free account |
4 | 4 | 3 | 3 |
| (780.21%) | (870.85%) | 1,574.52% | 308.17% | ||
| (17.39%) | (15.22%) | (10.48%) | (12.06%) | ||
ROIC |
(67.92%) | (61.12%) | (43.09%) | (63.07%) | |
Return on Tangible Assets |
(43.49%) | (36.66%) | (27.53%) | (32.34%) | |
Average Days of Receivables |
68.68 | 66.14 | 58.42 | 50.17 | |
Free Cash Flow per Share |
(0.23) | (0.13) | (0.15) | (0.11) | |
Free Cash Flow |
(3.99) | (2.26) | (2.53) | (2.00) | |
Capital Expenditures |
(0.05) | (0.14) | (0.23) | (0.27) | |
| Other line items | |||||
Cash ROIC |
(28.57%) | (15.38%) | (19.36%) | (16.51%) | |
Accounts Receivable Turnover |
5.85 | 5.87 | 5.91 | 6.03 | |
Accounts Payable Turnover |
5.90 | 5.41 | 5.71 | 5.52 | |
Inventory Turnover |
3.43 | 3.58 | 3.46 | 3.63 | |
Average Days of Payables |
51.40 | 58.76 | 62.37 | 73.45 | |
Days of Inventory on Hand |
85.11 | 85.96 | 101.10 | 107.71 | |
Tax Rate |
0.01 | 0.01 | 0.03 | 0.04 | |
Research and Development Expense of Revenue |
7.57% | 6.96% | 7.03% | 7.29% | |
Selling, General and Administrative Expense of Revenue |
36.65% | 34.42% | 34.06% | 34.02% | |
Share Based Compensation of Revenue |
1.73% | 1.47% | 1.47% | 1.41% | |
Operating CF/Net income |
0.77 | 0.48 | 0.70 | 0.49 | |
Depreciation/Fixed assets |
76.13 | 29.59 | 11.94 | 9.02 | |
Capex/Depreciation |
(0.03) | (0.08) | (0.14) | (0.16) | |
Revenue per Share |
2.98 | 3.11 | 3.04 | 2.96 | |
Operating CF per Share |
(0.23) | (0.12) | (0.13) | (0.10) | |
Capex per Share |
0.00 | (0.01) | (0.01) | (0.02) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.01 |
Columns are period end dates